Literature DB >> 28138578

Ethnicity-related differences in tumor immunity: a new possible explanation for gastric cancer prognostic variability?

Daniele Marrelli1, Karol Polom1, Franco Roviello1.   

Abstract

Entities:  

Year:  2016        PMID: 28138578      PMCID: PMC5244797          DOI: 10.21037/tgh.2016.03.03

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


× No keyword cloud information.
  20 in total

1.  Explaining gastric cancer survival differences among European countries.

Authors:  Arduino Verdecchia; Isabella Corazziari; Gemma Gatta; Daniele Lisi; Jean Faivre; David Forman
Journal:  Int J Cancer       Date:  2004-05-01       Impact factor: 7.396

2.  Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy.

Authors:  Daniele Marrelli; Corrado Pedrazzani; Giovanni Corso; Alessandro Neri; Marianna Di Martino; Enrico Pinto; Franco Roviello
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

3.  Changing clinical and pathological features of gastric cancer over time.

Authors:  D Marrelli; C Pedrazzani; P Morgagni; G de Manzoni; F Pacelli; A Coniglio; A Marchet; L Saragoni; S Giacopuzzi; F Roviello
Journal:  Br J Surg       Date:  2011-05-10       Impact factor: 6.939

4.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

5.  Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

Authors:  X-J Wu; R-L Miao; Z-Y Li; Z-D Bu; L-H Zhang; A-W Wu; X-L Zong; S-X Li; F Shan; X Ji; H Ren; J-F Ji
Journal:  Eur J Surg Oncol       Date:  2015-04-03       Impact factor: 4.424

6.  Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer.

Authors:  Daniel D Kirchoff; Gary B Deutsch; Manabu Fujita; David Y Lee; Myung Shin Sim; Ji Hey Lee; Anton J Bilchik
Journal:  J Gastrointest Surg       Date:  2015-08-26       Impact factor: 3.452

7.  Survival trends in European cancer patients diagnosed from 1988 to 1999.

Authors:  Arduino Verdecchia; Stefano Guzzinati; Silvia Francisci; Roberta De Angelis; Freddie Bray; Claudia Allemani; Andrea Tavilla; Mariano Santaquilani; Milena Sant
Journal:  Eur J Cancer       Date:  2009-01-03       Impact factor: 9.162

8.  Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis.

Authors:  Jung Ho Shim; Kyo Young Song; Hae Myung Jeon; Cho Hyun Park; Lindsay M Jacks; Mithat Gonen; Manish A Shah; Murray F Brennan; Daniel G Coit; Vivian E Strong
Journal:  Ann Surg Oncol       Date:  2014-03-06       Impact factor: 5.344

9.  Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.

Authors:  Suling J Lin; Johann A Gagnon-Bartsch; Iain Beehuat Tan; Sophie Earle; Louise Ruff; Katherine Pettinger; Bauke Ylstra; Nicole van Grieken; Sun Young Rha; Hyun Cheol Chung; Ju-Seog Lee; Jae Ho Cheong; Sung Hoon Noh; Toru Aoyama; Yohei Miyagi; Akira Tsuburaya; Takaki Yoshikawa; Jaffer A Ajani; Alex Boussioutas; Khay Guan Yeoh; Wei Peng Yong; Jimmy So; Jeeyun Lee; Won Ki Kang; Sung Kim; Yoichi Kameda; Tomio Arai; Axel Zur Hausen; Terence P Speed; Heike I Grabsch; Patrick Tan
Journal:  Gut       Date:  2014-11-10       Impact factor: 23.059

10.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962

View more
  4 in total

Review 1.  Lymphadenectomy: state of the art.

Authors:  Daniele Marrelli; Lorenzo De Franco; Livio Iudici; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-17

Review 2.  What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives.

Authors:  Giuseppe Tirino; Luca Pompella; Angelica Petrillo; Maria Maddalena Laterza; Annalisa Pappalardo; Marianna Caterino; Michele Orditura; Fortunato Ciardiello; Gennaro Galizia; Ferdinando De Vita
Journal:  Int J Mol Sci       Date:  2018-09-07       Impact factor: 5.923

3.  A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study.

Authors:  O Türeci; U Sahin; H Schulze-Bergkamen; Z Zvirbule; F Lordick; D Koeberle; P Thuss-Patience; T Ettrich; D Arnold; F Bassermann; S E Al-Batran; K Wiechen; K Dhaene; D Maurus; M Gold; C Huber; A Krivoshik; A Arozullah; J W Park; M Schuler
Journal:  Ann Oncol       Date:  2019-09-01       Impact factor: 32.976

4.  Durable Complete Radiological Response to Nivolumab in Two Heavily Pretreated Western Elderly Patients With Metastatic Gastric Cancer: A Case Report.

Authors:  Giuseppe Tirino; Angelica Petrillo; Luca Pompella; Annalisa Pappalardo; Maria Maddalena Laterza; Iacopo Panarese; Rosalaura Sabetta; Renato Franco; Gennaro Galizia; Fortunato Ciardiello; Ferdinando De Vita
Journal:  Front Oncol       Date:  2020-02-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.